Compare $AMFL vs $OTLC | Chartloom

Compare

$AMFL vs $OTLC

American Films Inc · Oncotelic Therapeutics Inc

AMFL

American Films Inc

OTLC

Oncotelic Therapeutics Inc

Compare $AMFL vs $OTLC

Comparing American Films Inc and Oncotelic Therapeutics Inc

AMFLAmerican Films Inc

OTLCOncotelic Therapeutics Inc

AMFLAmerican Films Inc

Market cap

$8M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

184.4%

52W performance

30.1%

FCF yield

-1.3%

OTLCOncotelic Therapeutics Inc

Market cap

$9M

P/E (TTM)

0.04x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-74.0%

52W performance

-76.9%

FCF yield

-16.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AMFL

OTLC

Detailed metrics comparison

AMFL

American Films Inc

OTLC

Oncotelic Therapeutics Inc

Market Cap

AMFL$8M

OTLC$9M

Enterprise Value

AMFL$10M

OTLC$23M

Price

AMFL$0.13

OTLC$0.02

P/E Ratio

AMFLN/A

OTLC0.04x

P/S Ratio

AMFL0.00x

OTLC36.91x

EV/Sales

AMFL0.00x

OTLC91.75x

EV/EBITDA

AMFL0.00x

OTLC0.00x

P/B Ratio

AMFLN/A

OTLC0.04x

P/FCF Ratio

AMFLN/A

OTLCN/A

EV/FCF

AMFL-91.69x

OTLC-15.05x

PEG Ratio

AMFLN/A

OTLCN/A

Forward P/E (NTM)

AMFLN/A

OTLCN/A

Forward P/S (NTM)

AMFLN/A

OTLCN/A

Revenue (TTM)

AMFL$0

OTLC$250K

Revenue Growth (YoY)

AMFLN/A

OTLCN/A

Forward Rev Growth

AMFL0.0%

OTLC0.0%

Gross Margin (TTM)

AMFL0.0%

OTLC83.1%

Operating Margin (TTM)

AMFL0.0%

OTLC0.0%

EBITDA Margin (TTM)

AMFL0.0%

OTLC-1545.3%

Net Margin (TTM)

AMFL0.0%

OTLC99875.6%

FCF Margin (TTM)

AMFLN/A

OTLC-609.8%

Net Income (TTM)

AMFL$-906K

OTLC$250M

FCF (TTM)

AMFL$-107K

OTLC$-2M

EPS (TTM)

AMFL-$0.08

OTLC$0.53

ROE (TTM)

AMFL0.0%

OTLC139.7%

ROA (TTM)

AMFL0.0%

OTLC91.8%

ROIC (TTM)

AMFL0.0%

OTLC129.6%

Cash

AMFL$0

OTLC$186K

Debt

AMFL$2M

OTLC$14M

Net Cash/Debt

AMFL$-2M

OTLC$-14M

Current Ratio (TTM)

AMFL0.00x

OTLC0.08x

Quick Ratio (TTM)

AMFL0.00x

OTLC0.01x

Debt/Equity (TTM)

AMFL0.00x

OTLC0.05x

Debt/Assets (TTM)

AMFL0.0%

OTLC0.0%

Interest Coverage (TTM)

AMFLN/A

OTLCN/A

Net Debt/EBITDA (TTM)

AMFL0.00x

OTLC0.00x

Beta

AMFL-1.40

OTLC-0.07

52W Performance

AMFL30.1%

OTLC-76.9%

YTD Performance

AMFL184.4%

OTLC-74.0%

% from 52W High

AMFL-24.3%

OTLC-81.1%

% from 52W Low

AMFL770.7%

OTLC4.0%

Asset Turnover (TTM)

AMFL0.00x

OTLC0.00x

FCF Yield (TTM)

AMFL-1.3%

OTLC-16.5%

Earnings Yield (TTM)

AMFL-11.1%

OTLC2706.0%

Dividend Yield (TTM)

AMFLN/A

OTLCN/A

Rule of 40

AMFL0.0

OTLC-609.8

EV/GP/RG

AMFLN/A

OTLCN/A

Ticker research

View AMFL research View OTLC research

Metric	AMFL American Films Inc	OTLC Oncotelic Therapeutics Inc
Market & Valuation
Market Cap	$8M	$9M
Enterprise Value	$10M	$23M
Price	$0.13	$0.02
P/E Ratio	N/A	0.04x
P/S Ratio	0.00x	36.91x
EV/Sales	0.00x	91.75x
EV/EBITDA	0.00x	0.00x
P/B Ratio	N/A	0.04x
P/FCF Ratio	N/A	N/A
EV/FCF	-91.69x	-15.05x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$250K
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	83.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-1545.3%
Net Margin (TTM)	0.0%	99875.6%
FCF Margin (TTM)	N/A	-609.8%
Net Income (TTM)	$-906K	$250M
FCF (TTM)	$-107K	$-2M
EPS (TTM)	-$0.08	$0.53
ROE (TTM)	0.0%	139.7%
ROA (TTM)	0.0%	91.8%
ROIC (TTM)	0.0%	129.6%
Financial Health
Cash	$0	$186K
Debt	$2M	$14M
Net Cash/Debt	$-2M	$-14M
Current Ratio (TTM)	0.00x	0.08x
Quick Ratio (TTM)	0.00x	0.01x
Debt/Equity (TTM)	0.00x	0.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.40	-0.07
52W Performance	30.1%	-76.9%
YTD Performance	184.4%	-74.0%
% from 52W High	-24.3%	-81.1%
% from 52W Low	770.7%	4.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-1.3%	-16.5%
Earnings Yield (TTM)	-11.1%	2706.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-609.8
EV/GP/RG	N/A	N/A
Ticker research	View AMFL research	View OTLC research

Valuation

P/E Ratio

OTLC

0.04x

P/S Ratio

AMFL

0.00x

OTLC

36.91x

EV/FCF

AMFL

-91.69x

OTLC

-15.05x

Growth & revenue

Forward Revenue Growth

AMFL

0.0%

OTLC

0.0%

Profitability & performance

Gross Margin

OTLC

83.1%

AMFL

0.0%

ROE

OTLC

139.7%

AMFL

0.0%

FCF Yield %

AMFL

-1.3%

OTLC

-16.5%

52-Week Performance

AMFL

30.1%

OTLC

-76.9%

Detailed metrics comparison

AMFL

American Films Inc

OTLC

Oncotelic Therapeutics Inc

Market Cap

AMFL$8M

OTLC$9M

Enterprise Value

AMFL$10M

OTLC$23M

Price

AMFL$0.13

OTLC$0.02

P/E Ratio

AMFLN/A

OTLC0.04x

P/S Ratio

AMFL0.00x

OTLC36.91x

EV/Sales

AMFL0.00x

OTLC91.75x

EV/EBITDA

AMFL0.00x

OTLC0.00x

P/B Ratio

AMFLN/A

OTLC0.04x

P/FCF Ratio

AMFLN/A

OTLCN/A

EV/FCF

AMFL-91.69x

OTLC-15.05x

PEG Ratio

AMFLN/A

OTLCN/A

Forward P/E (NTM)

AMFLN/A

OTLCN/A

Forward P/S (NTM)

AMFLN/A

OTLCN/A

Revenue (TTM)

AMFL$0

OTLC$250K

Revenue Growth (YoY)

AMFLN/A

OTLCN/A

Forward Rev Growth

AMFL0.0%

OTLC0.0%

Gross Margin (TTM)

AMFL0.0%

OTLC83.1%

Operating Margin (TTM)

AMFL0.0%

OTLC0.0%

EBITDA Margin (TTM)

AMFL0.0%

OTLC-1545.3%

Net Margin (TTM)

AMFL0.0%

OTLC99875.6%

FCF Margin (TTM)

AMFLN/A

OTLC-609.8%

Net Income (TTM)

AMFL$-906K

OTLC$250M

FCF (TTM)

AMFL$-107K

OTLC$-2M

EPS (TTM)

AMFL-$0.08

OTLC$0.53

ROE (TTM)

AMFL0.0%

OTLC139.7%

ROA (TTM)

AMFL0.0%

OTLC91.8%

ROIC (TTM)

AMFL0.0%

OTLC129.6%

Cash

AMFL$0

OTLC$186K

Debt

AMFL$2M

OTLC$14M

Net Cash/Debt

AMFL$-2M

OTLC$-14M

Current Ratio (TTM)

AMFL0.00x

OTLC0.08x

Quick Ratio (TTM)

AMFL0.00x

OTLC0.01x

Debt/Equity (TTM)

AMFL0.00x

OTLC0.05x

Debt/Assets (TTM)

AMFL0.0%

OTLC0.0%

Interest Coverage (TTM)

AMFLN/A

OTLCN/A

Net Debt/EBITDA (TTM)

AMFL0.00x

OTLC0.00x

Beta

AMFL-1.40

OTLC-0.07

52W Performance

AMFL30.1%

OTLC-76.9%

YTD Performance

AMFL184.4%

OTLC-74.0%

% from 52W High

AMFL-24.3%

OTLC-81.1%

% from 52W Low

AMFL770.7%

OTLC4.0%

Asset Turnover (TTM)

AMFL0.00x

OTLC0.00x

FCF Yield (TTM)

AMFL-1.3%

OTLC-16.5%

Earnings Yield (TTM)

AMFL-11.1%

OTLC2706.0%

Dividend Yield (TTM)

AMFLN/A

OTLCN/A

Rule of 40

AMFL0.0

OTLC-609.8

EV/GP/RG

AMFLN/A

OTLCN/A

Ticker research

View AMFL research View OTLC research

Metric	AMFL American Films Inc	OTLC Oncotelic Therapeutics Inc
Market & Valuation
Market Cap	$8M	$9M
Enterprise Value	$10M	$23M
Price	$0.13	$0.02
P/E Ratio	N/A	0.04x
P/S Ratio	0.00x	36.91x
EV/Sales	0.00x	91.75x
EV/EBITDA	0.00x	0.00x
P/B Ratio	N/A	0.04x
P/FCF Ratio	N/A	N/A
EV/FCF	-91.69x	-15.05x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$250K
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	83.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-1545.3%
Net Margin (TTM)	0.0%	99875.6%
FCF Margin (TTM)	N/A	-609.8%
Net Income (TTM)	$-906K	$250M
FCF (TTM)	$-107K	$-2M
EPS (TTM)	-$0.08	$0.53
ROE (TTM)	0.0%	139.7%
ROA (TTM)	0.0%	91.8%
ROIC (TTM)	0.0%	129.6%
Financial Health
Cash	$0	$186K
Debt	$2M	$14M
Net Cash/Debt	$-2M	$-14M
Current Ratio (TTM)	0.00x	0.08x
Quick Ratio (TTM)	0.00x	0.01x
Debt/Equity (TTM)	0.00x	0.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.40	-0.07
52W Performance	30.1%	-76.9%
YTD Performance	184.4%	-74.0%
% from 52W High	-24.3%	-81.1%
% from 52W Low	770.7%	4.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-1.3%	-16.5%
Earnings Yield (TTM)	-11.1%	2706.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-609.8
EV/GP/RG	N/A	N/A
Ticker research	View AMFL research	View OTLC research